test

Kai-Keen Shiu

Oncology

24 years of experience
24 years of experience

PATIENT REVIEWS

5

Reviewed By

Doctify

About

Kai-Keen Shiu is a distinguished Medical Oncology Consultant specializing in the Gastrointestinal Oncology Service. He is also an Honorary Associate Professor at the UCL Cancer Institute. Dr. Shiu treats a variety of cancers including oesophageal, stomach, small bowel, colorectal, hepatobiliary cancers, and cancers of unknown primary (CUP). He serves as the UCLH Clinical Lead for the Cancer of Unknown Primary Service and the Acute Oncology Service.Dr. Shiu’s research interests are focused on immunotherapy for gastrointestinal malignancies and CUP, emphasizing clinical trials and translational research. He is the Chief Investigator or Principal Investigator for several GI and CUP immuno-oncology Phase 2 and 3 trials, including KEYNOTE 177, KEYNOTE 859, KEYNOTE 811, KEYNOTE 975, VESTIGE, POLEM, and CUPISCO. He chairs the NCRI MUO-CUP Workstream as part of the Living With and Beyond Cancer CSG and is a member of the NCRI Colorectal Advanced and Adjuvant Disease Subgroup. Additionally, he is the Principal Investigator of the UCL-UCLH GI + CUP Cancer Translational Research Biobank and collaborates with the GI Oncology and CUP subgroups at the UCL Cancer Institute and Francis Crick Institute.Dr. Shiu is a member of several professional organizations including ASCO, ESMO, and the Association of Cancer Physicians (UK). His expertise includes chemotherapy, targeted therapy, immunotherapy, clinical trials, immunotherapy research, gastrointestinal oncology research, cancer of unknown primary research, molecular profiling with solid and liquid biopsies, and biomarker-driven clinical trial design and implementation. He is committed to education, teaching oncology to UCL medical students, as well as oncology and non-oncology junior trainees. He frequently gives talks both nationally and internationally at conferences and other hospitals, sharing best practices and future perspectives in GI oncology research, CUP, immunotherapy, and novel trial designs.

Subspecialities

Bowel Cancer, Biliary Cancer, Cancer of Unknown Primary, Colon Cancer, Gastrointestinal Cancers, Medical Oncology, Small Bowel Cancer

All procedures

  • Chemotherapy
  • Clinical Trials
  • Immunotherapy
  • Targeted Therapy

All conditions

  • Bowel Cancer
  • Biliary Cancer
  • Cancer of Unknown Primary
  • Carcinoma of Unknown Primary
  • Colon Cancer
  • Gastrointestinal Cancers
  • Small Bowel Cancer

Languages

English

Qualifications

FRCP, PhD

Registered with

General Medical Council: 4634849

Locations

Sydney Street Outpatients and Diagnostic Centre, 102 Sydney Street Chelsea, London, SW3 6NJ

Unavailable

42-52 Nottingham Place, London, W1U 5NY

Unavailable

102 Sydney Street, Chelsea, London, SW3 6NJ

Unavailable

15-17 Lodge Road, London, NW8 7JA

Unavailable

95 Harley Street, London, W1G 6AF

Unavailable

Consultation Fees

New appointment: £350

New appointment: £200

Reviews

Overall Rating

Overall rating

Overall experience

5 / 5

Personal care received

5 / 5

Explanation of care provided

5 / 5

PATIENT REVIEWS

5

Reviewed By

Doctify